-transparent.png){kind=logo}
Two patients with advanced lymphoma, chronic cold agglutinin disease refractory to conventional therapy and severe, progressive anemia were treated with exchange plasma transfusion. Both experienced significant reduction in titers. The first patient, in whom the procedure was done manually, died with widespread lymphoma without achieving apparent clinical benefit. The second patient was exchanged using the Aminco Celltrifuge, with improvement in in vitro compatibility tests and transfusion tolerance. The technical details of continuous-flow centrifugation exchange plasma transfusion are described.
Related Publications
E G Taft, and
R P Propp, and
S A Sullivan
January 1985,
Vox sanguinis,
E G Taft, and
R P Propp, and
S A Sullivan
December 1978,
Journal of the American Veterinary Medical Association,
E G Taft, and
R P Propp, and
S A Sullivan
May 2024,
Internal medicine (Tokyo, Japan),
E G Taft, and
R P Propp, and
S A Sullivan
June 2015,
Hematology/oncology clinics of North America,
E G Taft, and
R P Propp, and
S A Sullivan
July 2020,
TH open : companion journal to thrombosis and haemostasis,
E G Taft, and
R P Propp, and
S A Sullivan
June 1992,
[Rinsho ketsueki] The Japanese journal of clinical hematology,
E G Taft, and
R P Propp, and
S A Sullivan
February 2024,
Annals of hematology,
E G Taft, and
R P Propp, and
S A Sullivan
June 2019,
Clinical advances in hematology & oncology : H&O,
E G Taft, and
R P Propp, and
S A Sullivan
January 1979,
American journal of hematology,
E G Taft, and
R P Propp, and
S A Sullivan
February 1987,
Annals of internal medicine,
